About Aerami Therapeutics

About company

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.